Matinas BioPharma increases authorized common stock to 500M shares

Matinas BioPharma Holdings, Inc.

Authorized common shares doubled from 250M to 500M effective Aug 6, 2025.
Shareholder approval obtained at 2025 annual meeting on June 23, 2025.
Total authorized capital stock is now 510M shares (500M common + 10M preferred).
Certificate of Amendment filed with Delaware Secretary of State.

item 5.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.